These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 237338)

  • 21. Plasmic degradation of human fibrinogen. II. Further characterization of fragment D.
    Furlan M; Beck EA
    Biochim Biophys Acta; 1973 May; 310(1):205-16. PubMed ID: 4197006
    [No Abstract]   [Full Text] [Related]  

  • 22. A synthetic iodinated polypeptide that inhibits polymerization of fibrinogen.
    Miale JB; Mende TJ
    Blut; 1971; 22(2):76-9. PubMed ID: 5112575
    [No Abstract]   [Full Text] [Related]  

  • 23. A deficiency in A alpha chain's N-terminal alanine residue as a major cause of the slow coagulation of fetal fibrinogen.
    Hasegawa N; Sasaki S
    Thromb Res; 1989 Jun; 54(6):595-602. PubMed ID: 2571197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The in vitro behaviour of electrolytically radioiodinated fibrinogen.
    Stevens AM; Noujaim AA; Shysh A; Ediss C; Hill JR
    Int J Nucl Med Biol; 1978; 5(2-3):83-7. PubMed ID: 752659
    [No Abstract]   [Full Text] [Related]  

  • 25. [Isoelectric focusing in a stable pH gradient of 1-3. The isoelectric point of swine pepsin].
    Strongin AIa; Levin ED; Stepanov VM
    Biokhimiia; 1973; 38(5):1098-100. PubMed ID: 4592476
    [No Abstract]   [Full Text] [Related]  

  • 26. Partial chemical characterization of the isolated gamma-chain of human fibrinogen.
    Mills DA; Liener IE
    Arch Biochem Biophys; 1969 Mar; 130(1):629-35. PubMed ID: 5778677
    [No Abstract]   [Full Text] [Related]  

  • 27. The NH2-terminal amino acids of the fibrinogen degradation products. Implications for fibrinogen structure.
    Marder VJ; Budzynski AZ
    Thromb Diath Haemorrh Suppl; 1973; 56():127-35. PubMed ID: 4281939
    [No Abstract]   [Full Text] [Related]  

  • 28. Carboxy-terminal structure of the chain of human IgA myeloma proteins.
    Prahl JW; Abel CA; Grey HM
    Biochemistry; 1971 May; 10(10):1808-12. PubMed ID: 4998234
    [No Abstract]   [Full Text] [Related]  

  • 29. The procoagulant in human urine: purification, assay and some biochemical and physiological properties.
    Aoki N; Von Kaulla KN
    Thromb Diath Haemorrh; 1966 Dec; 16(3):586-605. PubMed ID: 5996676
    [No Abstract]   [Full Text] [Related]  

  • 30. The quantitation of isotope loss with tyrosine loss in the canine fibrinogen-fibrin transformation.
    Dellenback RJ; Chien S
    Proc Soc Exp Biol Med; 1971 Jul; 137(3):751-8. PubMed ID: 4934703
    [No Abstract]   [Full Text] [Related]  

  • 31. [Role of microcoagulation in the catabolism of fibrinogen].
    Voronina IE
    Vopr Med Khim; 1974 May; 20(3):268-72. PubMed ID: 4134548
    [No Abstract]   [Full Text] [Related]  

  • 32. Purification and partial characterization of four proteins from human parotid saliva.
    Bennick A; Connell GE
    Biochem J; 1971 Jul; 123(3):455-64. PubMed ID: 5001593
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protein A from Staphylococcus aureus. The effect of iodination on the reactivity with immunoglobulin G.
    Sjöholm I; Sjödin T
    Eur J Biochem; 1974 Sep; 47(3):491-8. PubMed ID: 4215655
    [No Abstract]   [Full Text] [Related]  

  • 34. Sialic acid dependent polypeptide chain heterogeneity of human fibrinogen demonstrated by two-dimensional electrophoresis.
    Kuyas C; Haeberli A; Straub PW
    Thromb Haemost; 1982 Feb; 47(1):19-21. PubMed ID: 7071802
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular composition and biological properties of soluble fibrin polymers encountered in thrombotic states.
    Bang NU; Hansen MS; Smith GF; Latallo ZS; Chang ML; Mattler LE
    Ser Haematol; 1973; 6(4):494-512. PubMed ID: 4277578
    [No Abstract]   [Full Text] [Related]  

  • 36. Fibrinogen degradation products in experimental intravascular coagulation. Gel filtration and immunological studies.
    Zetterqvist E
    Acta Physiol Scand; 1971 Jul; 82(3):289-99. PubMed ID: 4108400
    [No Abstract]   [Full Text] [Related]  

  • 37. Isoelectric focusing of fibrinogen degradation products.
    Arnesen H
    Scand J Haematol Suppl; 1971; 13():43-7. PubMed ID: 5290702
    [No Abstract]   [Full Text] [Related]  

  • 38. The microfibrillar proteins of human hair: separation by high-performance liquid chromatography and isolation of some proteins enriched in glycine and tyrosine.
    Said HM; Feige AJ; Newsom AE; Lauren SL; Mathews RA
    Anal Biochem; 1987 Aug; 165(1):161-6. PubMed ID: 3688430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterisation and comparison of macromolecular end products of fibrinogen and fibrin proteolysis by plasmin.
    Dudek GA; Kloczewiak M; Budzyński AZ; Latallo ZS; Kopeć M
    Biochim Biophys Acta; 1970 Jul; 214(1):44-51. PubMed ID: 4249862
    [No Abstract]   [Full Text] [Related]  

  • 40. Metabolism and distribution of fibrinogen. I. Fibrinogen turnover in physiological conditions in humans.
    Collen D; Tytgat GN; Claeys H; Piessens R
    Br J Haematol; 1972 Jun; 22(6):681-700. PubMed ID: 5064500
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.